Has the sun set on κ 3-opioid receptors?

British Journal of Pharmacology

Volumn 147, Issue 4, 2006, Pages 349-350

  Connor, Mark ^a   Kitchen, Ian ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Analgesia; Naloxone benzoylhydrazone; Pharmacological fantasy; Receptor knock out

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA3 OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE BENZOYLHYDRAZONE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; NALOXONE; NARCOTIC ANTAGONIST;

AGONIST; ANALGESIA; BINDING AFFINITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; IN VIVO STUDY; KNOCKOUT MOUSE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; ANIMAL; DRUG POTENTIATION; GENETICS; MALE; NOTE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 33644519023     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706603     Document Type: Review

References (12)

1. BERTZETEI-GURKE, I.P., WHITE, A., POLGAR, W., DECOSTA, B.R., PASTERNAK, G.W. & TOLL, L. (1995). The in vitro pharmacological characterization of naloxone benzoylhydrazone. Eur. J. Pharmacol., 277, 257-263.
2. 3 subtype. J. Pharmacol. Exp. Ther., 251, 461-468.
3. COX, V., CLARKE, S., CZYZYK, T., ANSONOFF, M., NITSCHE, J., HSU, M-S, BORSODI, A., TOMBOLY, C., TOTH, G., HILL, R., PINTAR, J. & KITCHEN, I. (2005). Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone. Neuropharmacology, 48, 228-235.
4. LORD, J.A.H., WATERFIELD, A.A., HUGHES, J. & KOSTERLITZ, H.W. (1977). Endogenous opioid peptides: multiple agonists and receptors. Nature, 267, 495-499.
5. MARTIN, W.R., EADES, C.G., THOMPSON, J.A., HUPPLER, R.E. & GILBERT, P.E. (1976). The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther., 197, 517-532.
6. NODA, Y., MAMIYA, T., NABESHIMA, T., NISHI, M., HIGASHIOKA, M. & TAKESHIMA, H. (1998). Loss of antinociception induced by naloxone benzylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem., 273, 18047-18051.
7. OLIANAS, M.C., CONCAS, D. & ONALI, P. (2006). Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.. Br. J. Pharmacol., 147, 360-370 (this issue).
8. ONALI, P. & OLIANAS, M.C. (2004). G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of the rat olfactory bulb. Br. J. Pharmacol., 143, 638-648.
9. 3-related opioid receptor. Mol. Pharmacol., 47, 1180-1188.
10. PAUL, D., LEVISON, J.A., HOWARD, D.H., PICK, C.G., HAHN, E.F. & PASTERNAK, G.W. (1990). Naloxone benzoylhydrazone (NalBzoH) analgesia. J. Pharmacol. Exp. Ther., 255, 769-774.
11. 3H]naloxone benzoylhydrazone: a reversible κ and slowly dissociable μ opiate. Mol. Pharmacol., 35, 67-74.
12. TRAYNOR, J. (1989). Subtypes of the κ-opioid receptor: fact or fiction? Trends Pharmacol. Sci., 10, 52-53.